Thirty‐four amino acid residues in EGFR, ALK, ROS1, RET, NTRK1, and MET proteins contained secondary/tertiary mutations and were reproducibly identified in clinical samples obtained from NSCLCs (and other type of cancers for RET/NTRK fusions). The gene discussed is RET; the disease is cancer.